The price of dialysis access: Implications of access type and patient-centric approaches to cost
The Journal of Vascular Access · 2025
DOI: 10.1177/11297298241290548 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Nathan Sim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Division of Interventional Radiology and Image-Guided Medicine, Emory School of Medicine, Atlanta, GA, …. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Renal Dialysis, Blood Vessel Prosthesis Implantation, Peritoneal Dialysis. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Harvey L. Neiman Health Policy Institute.
Abstract (Originalsprache)
Purpose
This study explores out-of-pocket (OOP) costs for patients and provider reimbursement for dialysis access creation. It aims to illustrate the financial characteristics of four dialysis access modalities to consider in decision-making for clinicians, patients, and payers. Materials and methods: Retrospective data from the Merative™ MarketScan Commercial Claims and Encounters Databases from 2017 to 2022 was analyzed for patients who received an arteriovenous fistula (AVF), arteriovenous graft (AVG), peritoneal dialysis catheter (PDC), or percutaneous AVF (pAVF). ANOVA and Tukey HSD were used to assess cost differences among the four access modalities overall and in the context of insurance type and service site.
Results
Database extraction resulted in 20,863 unique procedures, comprising of 15,043 AVF, 4759 AVG, 896 PDC, and 165 pAVF. Mean age was 59.2 years (±14.19) and 60.53% of the cohort was male. EPO/PPO plans were the most represented (53.06%) and most procedures were performed in the hospital outpatient department (91.99%). There were significant differences found among OOP cost and reimbursement with respect to procedure type, insurance type, and service site. Overall, pAVF had both the highest cost and reimbursement.
Conclusion
Patient OOP costs and provider reimbursement differ significantly based on procedure, insurance type, and service site. While pAVF creation is recognized with high reimbursements due to its complexity and the advanced technology required, it also has the highest OOP costs for patients. To help facilitate adoption of new technologies like pAVF, advocacy efforts should focus on encouraging payers to lower the OOP financial barriers for patients to receive these newer but costlier procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Imaging Sciences, Division of Interventional Radiology and Image-Guided Medicine, Emory School of Medicine, Atlanta, GA, USA.
- Wayne State University School of Medicine, Detroit, MI, USA.
- George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
- Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
ORCID-Profile: Nathan Sim
Förderung
- Harvey L. Neiman Health Policy Institute
Zitieren
APA
Sim, N., Li, H., Moon, J. T., Bikmal, A., Iyer, D., Byun, B., Konstantinidis, M., Teodorescu, V., Newsome, J., & Bercu, Z. (2025). The price of dialysis access: Implications of access type and patient-centric approaches to cost. The Journal of Vascular Access. https://doi.org/10.1177/11297298241290548
Vancouver
Sim N, Li H, Moon JT, Bikmal A, Iyer D, Byun B, et al. The price of dialysis access: Implications of access type and patient-centric approaches to cost. The Journal of Vascular Access. 2025. doi:10.1177/11297298241290548
BibTeX
@article{Sim2025,
author = {Sim, Nathan and Li, Hanzhou and Moon, John T and Bikmal, Anirudh and Iyer, Deepak and Byun, Brian and Konstantinidis, Menelaos and Teodorescu, Victoria and Newsome, Janice and Bercu, Zachary},
title = {The price of dialysis access: Implications of access type and patient-centric approaches to cost},
journal = {The Journal of Vascular Access},
year = {2025},
doi = {10.1177/11297298241290548}
}
EUVIMED